Cime Therapeutics
Cime Therapeutics is a startup headquartered in Denver, United States, founded in 2024. It has raised at least $2.1m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the seed stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Cime Therapeutics has raised at least $2.1m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Cime Therapeutics sits inside the Colorado Front Range R&D ecosystem in the Global R&D Labs Directory.
Other startups in Denver
- AidKit
- Aoa DX
- Azak
- Barrell Lithium
- CapExpert Co
- Cascade Biocatalysts
- Committee of Five
- Condor Global Forestry Products
- Deterrence Defense
- Earlytrade US Holdings
- Elemental Agronomy
Related
- Innovation profile of Denver
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Cime Therapeutics do?
Cime Therapeutics is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has Cime Therapeutics raised?
At least $2.1m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Cime Therapeutics based?
Cime Therapeutics is headquartered in Denver, United States.
When was Cime Therapeutics founded?
Cime Therapeutics was founded in 2024.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.